IFNA1 and systemic lupus erythematosus: This finding clearly indicates that the aberrant B cell response in SLE (directly or indirectly) triggers the enhanced IFN signature observed in PBMCs of patients with SLE and suggests that the increase in type I IFN signaling is a consequence rather than a cause of the increased activation of autoreactive B cells in SLE.